Short communicationInhibition of striatal energy metabolism produces cell loss in the ipsilateral substantia nigra
Section snippets
Acknowledgements
This research was supported by grants from the National Parkinson's Foundation and US Public Health Service Grants AG 08479 and NS 30406.
References (18)
- et al.
Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP
Brain Res.
(1996) - et al.
Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease
J. Neurol. Sci.
(1991) - et al.
The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse
Neurodegeneration
(1996) - et al.
Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat
Neuroscience
(1994) - et al.
In vivo vulnerability of dopamine neurons to inhibition of energy metabolism
Eur. J. Pharmacol.
(1997) - et al.
Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid
J. Neurosci.
(1993) - et al.
Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes
Brain
(1993) - et al.
Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid
J. Neurochem.
(1993) Enzymatic oxidation of dopamine: The role of prostaglandin H synthase
J. Neurochem.
(1995)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 1997 Elsevier Science B.V. All rights reserved.